Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» elranatamab
elranatamab
This Cancer Drug Candidate Could Be a Hit for Pfizer
Motley Fool
Sun, 03/26/23 - 11:19 pm
Pfizer
elranatamab
Multiple Myeloma
Pfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma
Drugs.com
Fri, 11/4/22 - 11:03 am
Pfizer
elranatamab
FDA
breakthrough therapy
relapsed or refractory multiple myeloma
Pfizer halts BCMA trial amid safety woes, hit by DMD delay
Fierce Biotech
Tue, 05/4/21 - 10:53 am
Pfizer
BCMA
clinical trials
Duchenne Muscular Dystrophy
elranatamab
fordadistrogene movaparvovec